Ana Lima-Pinheiro holds a master’s degree in Health Sciences taken at the School of Medicine and a bachelor’s in Applied Biology at the School of Sciences, both from the University of Minho. During her master’s, ALP developed Plasmodium falciparum transgenic lines with genetically encoded redox fluorescence biosensors to evaluate the impact of antimalarials in parasite homeostasis. As a master, ALP had a research fellow in the project “MalPharm – A genetic sensors-based high-throughput screening platform for antimalarial development”, which was focused on the screening of antimalarials mechanisms of action. Following up on the MalPharm project, ALP is currently working on the project “Mechanisms of action and resistance to the antimalarial Purydrazide” under Doctor Pedro Ferreira’s supervision. The project aims to deeply explore the group of drugs that showed up as potential candidates for antimalarials, Purydrazides. The aim is to identify novel drug targets in P. falciparum with the ability to delay drug resistance development.